Loading...
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
BACKGROUND: Trastuzumab emtansine (T-DM1) is an antibody–drug conjugate incorporating the human epidermal growth factor receptor 2 (HER2)–targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1. The antibody and the cytotoxic agent are conjuga...
Na minha lista:
| Udgivet i: | N Engl J Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5125250/ https://ncbi.nlm.nih.gov/pubmed/23020162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1209124 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|